The impact of Radioresistant-Related Telomere Genes in the prognosis and immune infiltration in lung adenocarcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Radiotherapy-related telomere genes (RRTGs) significantly impact lung adenocarcinoma (LUAD) prognosis and immune infiltration. A novel RRTGs score predicts overall survival and aids in understanding LUAD treatment strategies.
Area Of Science
- Oncology
- Genetics
- Radiotherapy Research
Background
- Lung adenocarcinoma (LUAD) presents a high mortality rate.
- Telomere genes influence radiation therapy response and cancer prognosis.
- The role of Radioresistant-Related Telomere Genes (RRTGs) in LUAD prognosis and immune infiltration is not well understood.
Purpose Of The Study
- To investigate the role of RRTGs in LUAD prognosis and immune cell infiltration.
- To develop a predictive model for overall survival using RRTGs.
- To explore the underlying mechanisms of RRTGs in LUAD.
Main Methods
- Utilized bioinformatics analysis on public and private datasets.
- Examined genetic and transcriptional differences, predictive significance, and expression profiles of RRTGs.
- Developed an RRTGs score and nomograms for clinical application.
- Assessed associations between RRTGs, immune cell infiltration, prognosis, and treatment.
- Performed Gene Set Enrichment Analysis (GSEA) and experimental validation (Western blot, qRT-PCR, Immunohistochemistry).
Main Results
- Identified a correlation between telomere-related genes and LUAD patient prognosis.
- Developed an RRTGs score based on ARRB1, PLK1, and DSG2 to predict overall survival.
- Demonstrated that RRTGs score can assess immune cell infiltration, tumor mutational burden, and survival probabilities.
- GSEA indicated RRTGs modulate immune-related pathways and cell cycle/DNA repair processes.
- ARRB1 and PLK1 were upregulated in radiosensitive NSCLC tissues and cell lines.
Conclusions
- RRTGs are significant in determining LUAD patient outcomes.
- The study enhances understanding of radiotherapy, telomere genes, and LUAD prognosis.
- Identified RRTGs as potential therapeutic targets for LUAD treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...